A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback